November 08, 2023
1 min read
Save
Orthofix launches new bioactive synthetic graft
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Orthofix announced the 510(k) clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft.
- OsteoCove is intended for use in spine and orthopedic procedures.
Orthofix Medical Inc. announced the 510(k) clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft, according to a company press release.
OsteoCove, which is available in both a putty and strip configuration, is intended for use in spine and orthopedic procedures.
Made to provide “superior bone-forming capabilities,” OsteoCove features a specialized granule surface topography made of B-tricalcium phosphate, hydroxyapatite and type I bovine collagen, according to the release.
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.